Results 111 to 120 of about 3,221,112 (336)

Open-source software in medical imaging: development of OsiriX [PDF]

open access: yes, 2018
Purpose Open source software (oss) development for medical imaging enables collaboration of individuals and groups to produce high-quality tools that meet user needs.
Ratib, Osman, Rosset, Antoine
core  

Development of Software for Feature Model Rendering

open access: yes, 2006
This Master’s thesis is aimed at improving the management of artifacts in the context of a joint-project between Jönköping University with the SEMCO project and industrial partner, a company involved in developing software for safety components. Both have a slightly distinct interest but this project can serve both parties.
Abid, Saad Bin, Wei, Xian
openaire   +1 more source

Multi‐omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

open access: yesMolecular Oncology, EarlyView.
This study highlights the importance of multi‐omic analyses in characterizing colorectal cancers. Indeed, our analysis revealed a rare CMS1 exhibiting dampened immune activation, including reduced PD‐1 expression, moderate CD8+ T‐cell infiltration, and suppressed JAK/STAT pathway.
Livia Concetti   +10 more
wiley   +1 more source

Photo-realistic image synthesis in volume rendering for rapid prototyping and CAM applications (draft) [PDF]

open access: yes, 2002
This document describes some preliminary results of the application of direct volume visualization and realistic image synthesis techniques in Computer Aided Manufacturing (CAM) field.
Pili, Piero, Scalas, Alceste
core  

Neural-Augmented Static Analysis of Android Communication

open access: yes, 2018
We address the problem of discovering communication links between applications in the popular Android mobile operating system, an important problem for security and privacy in Android.
Abadi Martín   +9 more
core   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

A Parallel Rendering Algorithm for MIMD Architectures [PDF]

open access: yes
Applications such as animation and scientific visualization demand high performance rendering of complex three dimensional scenes. To deliver the necessary rendering rates, highly parallel hardware architectures are required.
Crockett, Thomas W., Orloff, Tobias
core   +1 more source

Enabling collaboration in virtual reality navigators [PDF]

open access: yes, 2004
In this paper we characterize a feature superset for Collaborative Virtual Reality Environments (CVRE), and derive a component framework to transform stand-alone VR navigators into full-fledged multithreaded collaborative environments.
Fairén González, Marta   +2 more
core   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy